How many clinical trials are there for Benign Skin Growth?

PlainTrial tracks 1 US clinical trials for Benign Skin Growth, of which 1 are currently recruiting.

Which interventions appear most often on Benign Skin Growth trial records?

Protoporphyrin IX is the most-linked intervention name on Benign Skin Growth records (1 trial links), followed by Ameluz 10% Topical Gel. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Benign Skin Growth?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Benign Skin Growth clinical trials

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Benign Skin Growth trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Benign Skin Growth: 1 US clinical trial tracked, 1 recruiting.

Benign Skin Growth is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Dartmouth-Hitchcock Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition benign-skin-growth

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Benign Skin Growth

Benign Skin Growth lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Benign Skin Growth on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Benign Skin Growth is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING 125 participants

Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Dartmouth-Hitchcock Medical Center

NCT07201376

Phase Distribution

Phase data not available

Top Sponsors

Dartmouth-Hitchcock Medical Center 1 trials

Named interventions

Most-linked intervention names on Benign Skin Growth records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Protoporphyrin IX Device

1 trials

Ameluz 10% Topical Gel Drug

1 trials

US sites by state

Facility locations filed on Benign Skin Growth trials. A trial with sites in several states counts in each.

New Hampshire 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Benign Skin Growth page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Benign Skin Growth trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Dartmouth-Hitchcock Medical Center sponsors the most Benign Skin Growth trials on record, review their full trial history before evaluating a specific study. See Dartmouth-Hitchcock Medical Center's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Benign Skin Growth condition card totals 1 registered trials; most-linked intervention Protoporphyrin IX; top US site state New Hampshire. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.